Catalyst Wire Dossier Catalyst Wire Dossier

XELIRI

Drug timelines are a Plus or Pro feature.

4 regulatory and trial events tracked for XELIRI, covering 2010-08-19 to 2021-08-30. Get the full timeline:

Most recent: Clinical Trial Update: A Study of Bevacizumab Plus XELOX/XELIRI for First-line Treatment in Unresectable Advanced Colorectal Cancer [Phase 2]

See pricing